4-3493070-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_173660.5(DOK7):​c.1084G>A​(p.Val362Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000419 in 1,575,436 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000039 ( 0 hom. )

Consequence

DOK7
NM_173660.5 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 2.88

Publications

1 publications found
Variant links:
Genes affected
DOK7 (HGNC:26594): (docking protein 7) The protein encoded by this gene is essential for neuromuscular synaptogenesis. The protein functions in aneural activation of muscle-specific receptor kinase, which is required for postsynaptic differentiation, and in the subsequent clustering of the acetylcholine receptor in myotubes. This protein can also induce autophosphorylation of muscle-specific receptor kinase. Mutations in this gene are a cause of familial limb-girdle myasthenia autosomal recessive, which is also known as congenital myasthenic syndrome type 1B. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
DOK7 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 10
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • fetal akinesia deformation sequence 3
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.18438435).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_173660.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
NM_173660.5
MANE Select
c.1084G>Ap.Val362Met
missense
Exon 7 of 7NP_775931.3
DOK7
NM_001301071.2
c.1084G>Ap.Val362Met
missense
Exon 7 of 10NP_001288000.1
DOK7
NM_001363811.2
c.652G>Ap.Val218Met
missense
Exon 5 of 8NP_001350740.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOK7
ENST00000340083.6
TSL:1 MANE Select
c.1084G>Ap.Val362Met
missense
Exon 7 of 7ENSP00000344432.5
DOK7
ENST00000643608.1
c.652G>Ap.Val218Met
missense
Exon 5 of 8ENSP00000495701.1
DOK7
ENST00000515886.5
TSL:2
c.154G>Ap.Val52Met
missense
Exon 4 of 4ENSP00000492194.1

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
11
AN:
152236
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000114
AC:
21
AN:
183564
AF XY:
0.000119
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000243
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000214
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000632
Gnomad OTH exome
AF:
0.00102
GnomAD4 exome
AF:
0.0000386
AC:
55
AN:
1423200
Hom.:
0
Cov.:
111
AF XY:
0.0000425
AC XY:
30
AN XY:
705746
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32914
American (AMR)
AF:
0.000275
AC:
11
AN:
40062
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25546
East Asian (EAS)
AF:
0.0000791
AC:
3
AN:
37922
South Asian (SAS)
AF:
0.0000243
AC:
2
AN:
82450
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42234
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5734
European-Non Finnish (NFE)
AF:
0.0000292
AC:
32
AN:
1097188
Other (OTH)
AF:
0.000118
AC:
7
AN:
59150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000723
AC:
11
AN:
152236
Hom.:
0
Cov.:
34
AF XY:
0.0000807
AC XY:
6
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41460
American (AMR)
AF:
0.000458
AC:
7
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000679
Hom.:
0
Bravo
AF:
0.000128
ExAC
AF:
0.0000587
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jun 06, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 16, 2024
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BP4

Fetal akinesia deformation sequence 1;C1850792:Congenital myasthenic syndrome 10 Uncertain:1
Aug 16, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 362 of the DOK7 protein (p.Val362Met). This variant is present in population databases (rs760157322, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with DOK7-related conditions. ClinVar contains an entry for this variant (Variation ID: 568767). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Fetal akinesia deformation sequence 3 Uncertain:1
Nov 28, 2024
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as VUS-3B. Evidence in support of pathogenic classification: Variant is present in gnomAD <0.01 for a recessive condition (v4: 66 heterozygote(s), 0 homozygote(s)). Evidence in support of benign classification: Missense variant consistently predicted to be tolerated by in silico tool or not conserved in placental mammals with a minor amino acid change. Additional information: Variant is predicted to result in a missense amino acid change from valine to methionine; This variant is homozygous; This gene is associated with autosomal recessive disease; Previous evidence of pathogenicity for this variant is inconclusive. It has been classified as a variant of uncertain significance by clinical laboratories (ClinVar); No published segregation evidence has been identified for this variant; No published functional evidence has been identified for this variant; No comparable missense variants have previous evidence for pathogenicity; Variant is not located in an established domain, motif, hotspot or informative constraint region; Loss of function is a known mechanism of disease in this gene and is associated with fetal akinesia deformation sequence 3 (MIM#618389) and congenital myasthenic syndrome 10 (MIM#254300); This variant has been shown to be both maternally and paternally inherited (biallelic) (by trio analysis).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.095
T
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.73
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.18
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
2.9
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.16
Sift
Benign
0.090
T
Sift4G
Benign
0.075
T
Polyphen
0.94
P
Vest4
0.091
MutPred
0.35
Gain of glycosylation at S358 (P = 0.0523)
MVP
0.53
MPC
0.0047
ClinPred
0.090
T
GERP RS
2.8
Varity_R
0.082
gMVP
0.11
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs760157322; hg19: chr4-3494797; API